Terazosin hydrochloride dihydrate is the hydrochloride salt dihydrate form of terazosin, a quinazoline derivative that selectively blocks alpha-1 adrenergic receptors, leading to vasodilation and reduced peripheral vascular resistance. It is primarily supplied as an active pharmaceutical ingredient for use in manufacturing finished dosage forms.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 70024-40-7
Terazosin HCl
active pharmaceutical ingredient
Terazosin
active pharmaceutical ingredient
2-Methyl-5-nitro-1H-imidazole-1-propanol monohydrochloride
Active pharmaceutical ingredient
Cimetidine hydrochloride
Active pharmaceutical ingredient
Galunisertib
active pharmaceutical ingredient
4-(Aminomethyl)cyclohexanecarboxylic acid
Antifibrinolytic active pharmaceutical ingredient
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride
NZMOFYDMGFQZLS-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl